As of the latest SEC filings, Vor Biopharma Inc. (VOR) is held by 36 institutional funds. The largest fund shareholder is Select Biotechnology Portfolio (FBIOX), holding an estimated $23,717,770.00 in market value, representing 0.44% of its portfolio.
Funds holding Vor Biopharma Inc. (VOR)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- VOR
- CIK:
- 0001817229
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.44% | $23,717,770.00 | 1,536,125 | Feb 28, 2026 | Apr 24, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $19,001,116.40 | 1,065,085 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.22% | $16,634,016.00 | 932,400 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $5,950,335.76 | 333,539 | Mar 31, 2026 | May 28, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.03% | $1,776,804.32 | 115,078 | Feb 27, 2026 | Apr 24, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.00% | $1,230,243.76 | 79,679 | Feb 28, 2026 | Apr 24, 2026 |
|
ITOT
iShares Core S&P Total U.S. Stock Market ETF
|
ETF | BlackRock / iShares | 0.00% | $1,166,950.08 | 65,412 | Mar 31, 2026 | May 28, 2026 |
|
SURI
Simplify Propel Opportunities ETF
|
ETF | Independent / Boutique | 1.38% | $954,618.40 | 53,510 | Mar 31, 2026 | May 27, 2026 |
|
BMEZ
BlackRock Health Sciences Term Trust
|
CEF | BlackRock / iShares | 0.08% | $779,786.40 | 43,710 | Mar 31, 2026 | May 28, 2026 |
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
ETF | Direxion | 0.15% | $778,950.14 | 54,358 | Apr 30, 2026 | Jun 29, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $511,542.64 | 33,131 | Feb 28, 2026 | Apr 24, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $410,410.64 | 26,581 | Feb 28, 2026 | Apr 24, 2026 |
|
FNCMX
Fidelity Nasdaq Composite Index Fund
|
MF | Fidelity | 0.00% | $372,891.44 | 24,151 | Feb 28, 2026 | Apr 24, 2026 |
|
VBINX
VANGUARD BALANCED INDEX FUND
|
MF | Vanguard | 0.00% | $334,856.80 | 18,770 | Mar 31, 2026 | May 28, 2026 |
|
SWTSX
Schwab Total Stock Market Index Fund
|
MF | Charles Schwab | 0.00% | $318,183.32 | 22,204 | Apr 30, 2026 | Jun 25, 2026 |
|
VITNX
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND
|
MF | Vanguard | 0.00% | $280,123.68 | 15,702 | Mar 31, 2026 | May 28, 2026 |
|
BIPIX
BIOTECHNOLOGY ULTRASECTOR PROFUND
|
MF | Independent / Boutique | 0.13% | $241,087.92 | 16,824 | Apr 30, 2026 | Jun 22, 2026 |
|
SPWIX
SIMT Small Cap Growth Fund
|
MF | Independent / Boutique | 0.09% | $235,773.44 | 13,216 | Mar 31, 2026 | May 29, 2026 |
|
BME
BlackRock Health Sciences Trust
|
CEF | BlackRock / iShares | 0.03% | $178,756.80 | 10,020 | Mar 31, 2026 | May 28, 2026 |
|
GARTX
Goldman Sachs Absolute Return Tracker Fund
|
MF | Goldman Sachs | 0.00% | $162,219.12 | 9,093 | Mar 31, 2026 | May 26, 2026 |
|
PRFZ
Invesco RAFI US 1500 Small-Mid ETF
|
ETF | Invesco | 0.00% | $131,148.16 | 9,152 | Apr 30, 2026 | Jun 26, 2026 |
|
-
Health Sciences Portfolio
|
ETF | Independent / Boutique | 0.03% | $122,435.92 | 6,863 | Mar 31, 2026 | May 27, 2026 |
|
PEXMX
T. Rowe Price Extended Equity Market Index Fund
|
MF | T. Rowe Price | 0.01% | $117,744.00 | 6,600 | Mar 31, 2026 | May 28, 2026 |
|
BRSIX
Ultra-Small Company Market Fund
|
MF | Independent / Boutique | 0.09% | $111,500.00 | 6,250 | Mar 31, 2026 | May 21, 2026 |
|
-
PROFUND VP BIOTECHNOLOGY
|
ETF | Independent / Boutique | 0.22% | $92,607.44 | 5,191 | Mar 31, 2026 | May 20, 2026 |
Advertisement (320x50)